Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients stratified by race

被引：0
|
作者：
Cohen, A. [1 ]
Sah, J. [2 ]
Dhamane, A. [3 ]
Lee, T. [4 ]
Rosenblatt, L. [3 ]
Hlavacek, P. [4 ]
Emir, B. [4 ]
Keshishian, A. [2 ]
Yuce, H. [5 ]
Luo, X. [6 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust London, Kings Coll London, Dept Med Hematol, London, England
[2] STATinMED Res, Ann Arbor, MI USA
[3] Bristol Myers Squibb Co, Lawrenceville, NJ USA
[4] Pfizer Inc, New York, NY USA
[5] CUNY, New York City Coll Technol, New York, NY 10021 USA
[6] Pfizer Inc, Groton, CT USA
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1940 / 1940
页数：1
相关论文
共 50 条
  • [21] HOSPITAL LENGTH OF STAY AMONG VENOUS THROMBOEMBOLISM PATIENTS TREATED WITH APIXABAN AND WARFARIN IN ENGLAND
    Carroll, R.
    Lambrelli, D.
    Donaldson, R.
    Ramagopalan, S.
    Alikhan, R.
    [J]. VALUE IN HEALTH, 2019, 22 : S552 - S552
  • [22] Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism
    Craig I. Coleman
    Alexander G. G. Turpie
    Thomas J. Bunz
    Jan Beyer-Westendorf
    [J]. Journal of Thrombosis and Thrombolysis, 2018, 46 : 339 - 345
  • [23] Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism
    Coleman, Craig I.
    Turpie, Alexander G. G.
    Bunz, Thomas J.
    Beyer-Westendorf, Jan
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 46 (03) : 339 - 345
  • [24] Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism
    Coleman, Craig I.
    Turpie, Alexander G. G.
    Bunz, Thomas J.
    Beyer-Westendorf, Jan
    [J]. AMERICAN JOURNAL OF MEDICINE, 2018, 131 (08): : 933 - +
  • [25] EFFECTIVENESS AND SAFETY OF RIVAROXABAN VERSUS WARFARIN IN PATIENTS WITH UNPROVOKED VENOUS THROMBOEMBOLISM
    Coleman, Craig I.
    Bunz, Thomas J.
    Peacock, W. Frank
    Martinez, Brandon K.
    Baker, William L.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E12 - E12
  • [26] COMPARATIVE EFFECTIVENESS OF APIXABAN VERSUS WARFARIN FOR TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH AND WITHOUT ACTIVE CANCER
    Wygant, Gail D.
    Guo, Jennifer
    Rosenblatt, Lisa
    Weycker, Derek
    Li, Shawn
    Lee, Theodore
    Luo, Xuemei
    Mardekian, Jack
    Hanau, Ahuva
    Atwood, Mark
    Pan, Xianying
    Cohen, Alexander
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1926 - 1926
  • [27] Effectiveness and Safety of Apixaban, Low-Molecular-Weight Heparin, and Warfarin among Venous Thromboembolism Patients with Active Cancer: A US Claims Data Analysis
    Cohen, Alexander
    Keshishian, Allison
    Lee, Theodore
    Wygant, Gail
    Rosenblatt, Lisa
    Hlavacek, Patrick
    Mardekian, Jack
    Wiederkehr, Daniel
    Sah, Janvi
    Luo, Xuemei
    [J]. THROMBOSIS AND HAEMOSTASIS, 2021, 121 (03) : 383 - 395
  • [28] Effectiveness and safety of apixaban, low-molecular weight heparin, and warfarin among high-risk subgroups of venous thromboembolism patients with active cancer
    Cohen, A.
    Keshishian, A.
    Lee, T.
    Wygant, G.
    Rosenblatt, L.
    Hlavacek, P.
    Sah, J.
    Luo, X.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 3369 - 3369
  • [29] Comparative effectiveness and safety of direct oral anticoagulants versus warfarin among patients with recurrent venous thromboembolism
    Kang, Hye-Rim
    Dietrich, Eric A.
    Huang, Pei-Lin
    Lo-Ciganic, Wei-Hsuan
    DeRemer, Christina E.
    Park, Haesuk
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (06): : 946 - 954
  • [30] Comparative Effectiveness, Safety, and Costs of Rivaroxaban and Warfarin Treatment Among Morbidly Obese Patients with Venous Thromboembolism
    Spyropoulos, Alex C.
    Ashton, Veronica
    Chen, Yen-Wen
    Wu, Bingcao
    Peterson, Eric D.
    [J]. BLOOD, 2018, 132
12345